XNK Therapeutics to present at Investival Showcase Meeting
XNK Therapeutics AB ("XNK”) today announced that Johan Liwing, CEO, will present the company at the at Investival Showcase Meeting in London, on November 13[th]The LSX Investival Showcase meeting is one of Europe’s biggest pitch events for early and growth stage companies. The meeting brings together over three hundred qualified life science investors. In addition, it serves as the kickoff to the Jefferies week, leading into the Jefferies London Healthcare Conference, where XNK will also participate.
The presentation is followed by a short Q&A session.
For more information, please